Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HAEMONETICS CORP Director's Dealing 2013

Nov 14, 2013

31565_dirs_2013-11-14_beb1f8ba-e3f7-479e-9fdb-0369481d3297.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HAEMONETICS CORP (HAE)
CIK: 0000313143
Period of Report: 2013-11-12

Reporting Person: FOOTE SUSAN BARTLETT (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-11-12 Common Stock S 2062.0 $39.8201 Disposed 9939 Direct